Understanding the impact of multimorbidity on chronic airway diseases
Official title: Chronic Airway Disease and Multimorbidity (CAM) Cohort: Protocol of a Prospective Multicenter Observational Cohort Study
Run by China-Japan Friendship Hospital · NCT06798077 · Data updated 2026-11-12
This study looks at how having multiple health issues affects people with chronic lung diseases like COPD, asthma, or bronchiectasis to help improve their care and treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | China-Japan Friendship Hospital Academic / other |
| Locations | 9 sites (Beijing, Beijing Municipality and 8 other locations) |
| Status | Recruiting |
| Started | February 1, 2025 |
| Main results expected | July 31, 2028 |
| Study ends | July 31, 2028 |
| Registry record updated | February 17, 2025 |
| Trial ID | NCT06798077 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients aged 40 and older with chronic obstructive pulmonary disease or those aged 18 and older with asthma or bronchiectasis experiencing an acute exacerbation.
✕Probably not a fit
Patients with a life expectancy of less than one month or those with certain lung diseases like cystic fibrosis or interstitial lung disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Chronic Airway Disease and Multimorbidity (CAM) Cohort is a nationwide, prospective, multicenter observational study that aims to recruit at least 2,000 patients hospitalized for exacerbations of chronic obstructive pulmonary disease (COPD), asthma, or bronchiectasis. The study will collect comprehensive data on demographics, medical history, comorbidities, lung function, and quality of life during hospitalization and follow up with participants for one year post-discharge. By analyzing how multimorbidity affects treatment outcomes and healthcare utilization, the study seeks to provide insights into the management of chronic airway diseases.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies and better health outcomes for patients with chronic airway diseases and multimorbidity.
How similar studies have gone: While the impact of multimorbidity on chronic airway diseases is underexplored, similar observational studies have shown promise in understanding the complexities of comorbid conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with chronic obstructive pulmonary disease ≥40 years of age; patients with asthma and bronchiectasis ≥18 years of age; * The primary diagnosis on admission was "acute exacerbation of chronic obstructive pulmonary disease, uncontrolled asthma, or acute exacerbation of bronchiectasis". Exclusion Criteria: * Patients were unable to undergo spirometry during the stabilization period; * Expected survival is less than 1 month; * Refusal to sign an informed consent form; * Chest imaging showed emerging patchy infiltrating shadows, lobar or segmental solid shadows, ground glass shadows, or interstitial changes with or without pleural effusion; * Patients with cystic fibrosis or with interstitial lung disease or other lung diseases with tractional branchial dilatation.
Where it's running
-
National Center for Respiratory Medicine, China-Japan Friendship Hospital
Beijing, Beijing Municipality, China Recruiting -
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China Recruiting -
Henan Provincial People's Hospital
Zhengzhou, Henan, China Recruiting -
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China Recruiting -
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China Recruiting -
The First Affiliated Hospital of China Medical University
Shenyang, Liaoning, China Recruiting
Show 3 more locations
-
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China Recruiting -
Ruijin Hospital Affiliated to Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China Recruiting -
West China Hospital of Sichuan University
Chengdu, Sichuan, China Recruiting
Study contacts
- Principal investigator: Ting Yang, MD — China-Japan Friendship Hospital, National Center for Respiratory Medicine
- Study coordinator: Ke Huang, MD.
- Email: huangke_zryy@163.com
- Phone: +8615120079197
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
Registry for patients with chronic airway diseases
This study is gathering information from people with chronic airway diseases like COPD and asthma to better understand their conditions and find ways to improve their care.
-
Breathlessness in respiratory diseases: who feels it and why
This study tests how physiology, psychology, function, and breathing patterns relate to breathlessness in people with respiratory conditions compared with healthy controls.
-
Breztri real-world safety and effectiveness in Korean patients with COPD or asthma
This post-marketing study tests Breztri in real-world Korean patients with COPD or asthma to see how safe it is and how well it works when used as usual care.
-
Effects of Wood Smoke on Lung Health in Adults
This study tests how different levels of woodsmoke exposure affect lung function and inflammatory responses in healthy adults.
-
Immune status and disease control in airway inflammatory diseases
This project will test whether specific blood immune cell patterns relate to disease control in adults with asthma, COPD, bronchiectasis, or obstructive sleep apnea by comparing them with healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.